Free Access
Med Sci (Paris)
Volume 31, Number 1, Janvier 2015
Page(s) 53 - 59
Section M/S Revues
Published online 06 February 2015
  1. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med 2013 ; 368 : 745–755. [CrossRef] [PubMed] [Google Scholar]
  2. Lai RP, Nakiwala JK, Meintjes G, Wilkinson RJ. The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome. Eur J Immunol 2013 ; 43 : 1995–2002. [CrossRef] [PubMed] [Google Scholar]
  3. World-Health-Organization : Global tuberculosis report. 2013, URL: [Google Scholar]
  4. Aaron L, Saadoun D, Calatroni I, et al. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 2004 ; 10 : 388–398. [CrossRef] [PubMed] [Google Scholar]
  5. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006 ; 368 : 1575–1580. [CrossRef] [PubMed] [Google Scholar]
  6. Meintjes G, Lawn SD, Scano F. et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008 ; 8 : 516–523. [CrossRef] [PubMed] [Google Scholar]
  7. Breton G, Duval X, Estellat C. et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004 ; 39 : 1709–1712. [CrossRef] [PubMed] [Google Scholar]
  8. Muller M, Wandel S, Colebunders R. et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010 ; 10 : 251–261. [CrossRef] [PubMed] [Google Scholar]
  9. French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009 ; 48 : 101–107. [CrossRef] [PubMed] [Google Scholar]
  10. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004 ; 18 : 1615–1627. [CrossRef] [PubMed] [Google Scholar]
  11. Haddow LJ, Colebunders R, Meintjes G. et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010 ; 10 : 791–802. [CrossRef] [PubMed] [Google Scholar]
  12. Breton G., Schaaf HS, Zumla A. Immune reconstitution inflammatory syndrome. Tuberculosis: a comprehensive clinical reference 2009 ; Philadelphia Saunders, Elsevier 689–700. [Google Scholar]
  13. Pepper DJ, Marais S, Maartens G. et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009 ; 48 : e96–107. [CrossRef] [PubMed] [Google Scholar]
  14. French MA. The immunopathogenesis of mycobacterial immune restoration disease. Lancet Infect Dis 2006 ; 6 : 461–462. [CrossRef] [PubMed] [Google Scholar]
  15. Pean P, Nerrienet E, Madec Y. et al. Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. Blood 2012 ; 119 : 3315–3320. [CrossRef] [PubMed] [Google Scholar]
  16. Blanc FX, Sok T, Laureillard D. et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011 ; 365 : 1471–1481. [CrossRef] [PubMed] [Google Scholar]
  17. Abdool Karim SS, Naidoo K, Grobler A. et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011 ; 365 : 1492–1501. [CrossRef] [PubMed] [Google Scholar]
  18. Havlir DV, Kendall MA, Ive P. et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011 ; 365 : 1482–1491. [CrossRef] [PubMed] [Google Scholar]
  19. Morlat P. Prise en charge médicale des personnes vivant avec le VIH : Recommandations du groupe d’experts. Rapport 2013. Conseil national du Sida et Agence nationale de recherche sur le Sida et les hépatites virales 2013. URL: [Google Scholar]
  20. Bourgarit A, Carcelain G, Martinez V. et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006 ; 20 : F1–F7. [CrossRef] [PubMed] [Google Scholar]
  21. Mahnke YD, Greenwald JH, DerSimonian R. et al. Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. Blood 2012 ; 119 : 3105–3112. [CrossRef] [PubMed] [Google Scholar]
  22. Geldmacher C, Schuetz A, Ngwenyama N. et al. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J Infect Dis 2008 ; 198 : 1590–1598. [CrossRef] [PubMed] [Google Scholar]
  23. Geldmacher C, Ngwenyama N, Schuetz A. et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 2010 ; 207 : 2869–2881. [CrossRef] [PubMed] [Google Scholar]
  24. Tan DB, Yong YK, Tan HY. et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 2008 ; 9 : 307–316. [CrossRef] [PubMed] [Google Scholar]
  25. Elliott JH, Vohith K, Saramony S. et al. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 2009 ; 200 : 1736–1745. [CrossRef] [PubMed] [Google Scholar]
  26. Bourgarit A, Carcelain G, Samri A, et al. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J Immunol 2009; 183 : 3915–3923. [CrossRef] [PubMed] [Google Scholar]
  27. Sereti I, Rodger AJ, French MA. Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS 2010 ; 5 : 504–510. [CrossRef] [PubMed] [Google Scholar]
  28. Barber DL, Andrade BB, Sereti I, Sher A. Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol 2012 ; 10 : 150–156. [PubMed] [Google Scholar]
  29. Tadokera R, Meintjes G, Skolimowska KH. et al. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 2011 ; 37 : 1248–1259. [CrossRef] [PubMed] [Google Scholar]
  30. Lortholary O, Fontanet A, Memain N. et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005 ; 19 : 1043–1049. [CrossRef] [PubMed] [Google Scholar]
  31. Lawn SD, Wainwright H, Orrell C. Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 2009 ; 23 : 143–145. [CrossRef] [PubMed] [Google Scholar]
  32. Barber DL, Mayer-Barber KD, Antonelli LR. et al. Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 2010 ; 116 : 3485–3493. [CrossRef] [PubMed] [Google Scholar]
  33. Tan DB, Lim A, Yong YK. et al. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 2011 ; 25 : 1455–1460. [CrossRef] [PubMed] [Google Scholar]
  34. Porter BO, Ouedraogo GL, Hodge JN. et al. d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. Clin Immunol 2010 ; 136 : 42–50. [CrossRef] [PubMed] [Google Scholar]
  35. Narendran G, Andrade BB, Porter BO. et al. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PLoS One 2013 ; 8 : e63541. [CrossRef] [PubMed] [Google Scholar]
  36. Goovaerts O, Jennes W, Massinga-Loembe M. et al. LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients. PLoS One 2013 ; 8 : e81856. [CrossRef] [PubMed] [Google Scholar]
  37. Oliver BG, Elliott JH, Price P. et al. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis 2010 ; 202 : 1728–1737. [CrossRef] [PubMed] [Google Scholar]
  38. Chakrabarti LA, Boucherie C, Bugault F. et al. Biomarkers of CD4+ T cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2014 ; 28 : 1593–1602. [CrossRef] [PubMed] [Google Scholar]
  39. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011 ; 62 : 141–155. [CrossRef] [PubMed] [Google Scholar]
  40. Napolitano LA, Grant RM, Deeks SG. et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001 ; 7 : 73–79. [CrossRef] [PubMed] [Google Scholar]
  41. Chahroudi A, Silvestri G. Interleukin-7 in HIV pathogenesis and therapy. Eur Cytokine Netw 2010 ; 21 : 202–207. [PubMed] [Google Scholar]
  42. Juffroy O, Bugault F, Lambotte O. et al. Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol 2010 ; 84 : 96–108. [CrossRef] [PubMed] [Google Scholar]
  43. Landires I, Bugault F, Lambotte O. et al. HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization. AIDS 2011 ; 25 : 1843–1853. [CrossRef] [PubMed] [Google Scholar]
  44. Seddiki N, Sasson SC, Santner-Nanan B, et al. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009; 39 : 391–403. [CrossRef] [PubMed] [Google Scholar]
  45. Antonelli LR, Mahnke Y, Hodge JN. et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 2010 ; 116 : 3818–3827. [CrossRef] [PubMed] [Google Scholar]
  46. Borand L, Pheng P, Saman M. et al. Co-infection tuberculose et VIH. Med Sci (Paris) 2013 ; 29 : 908–911. [CrossRef] [EDP Sciences] [Google Scholar]
  47. Veziris N, Robert J. Résistance aux antituberculeux et impasse thérapeutique. Med Sci (Paris) 2010 ; 26 : 976–980. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  48. Breton G.. Syndrome inflammatoire de reconstitution immune. Med Sci (Paris) 2010 ; 26 : 281–290. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  49. Gouzy A. Yannick Poquet Y, Neyrolles O. L’aspartate : un acide aminé essentiel à la physiologie et à la virulence du bacille de la tuberculose. Med Sci (Paris) 2014 ; 30 : 242–244. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.